Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Esperion Theraptc (ESPR)

37.54 -0.15 (-0.4%)

05-25 16:00

Open:

37.51

Pre. Close:

37.69

High:

38.07

Low:

36.8783

Volume:

714,934

Market Cap:

1006M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

38.112 - 38.422

38.422 - 38.631

Low:

36.241 - 36.581

36.581 - 36.809

Close:

37.091 - 37.622

37.622 - 37.979

Technical analysis  (as of: 2018-05-25 4:34:24 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 68.87     One year: 87.56

Support:

Support1: 33.06    Support2: 27.51

Resistance:

Resistance1: 58.96    Resistance2: 74.97

Pivot:

40.37

Moving Averages:

MA(5): 38.24     MA(20): 43.52

MA(100): 67.13     MA(250): 56.34

MACD:

MACD(12,26): -6.96     Signal(12,26,9): -7.37

%K %D:

%K(14,3): 29.14     %D(3): 29.65

RSI:

RSI(14): 28.74

52-Week:

High: 82.68  Low: 30.95  Change(%): 19.1

Average Vol(K):

3-Month: 133043  10-Days 116618

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ESPR has closed above bottom band by 8.0%. Bollinger Bands are 61.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ESPR's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-25T21:40:53-04:00
For Esperion, The Only Trial That Matters Is CLEAR Outcomes Due In 2022

2018-05-25T13:39:00-04:00
INVESTOR ALERT: Kirby McInerney LLP Advises Esperion Therapeutics, Inc. (ESPR) Investors of Potential Claims

2018-05-25T13:17:48-04:00
Esperion Therapeutics (ESPR) Presents At 2018 UBS Global Healthcare Conference - Slideshow

2018-05-25T11:49:00-04:00
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018

2018-05-24T18:05:00-04:00
Esperion Aces Third Study, Shows That Safety Issues Were Overblown

2018-05-24T15:16:00-04:00
The Klein Law Firm Announces a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)

2018-05-24T12:00:00-04:00
Your Daily Pharma Scoop: Esperion Shows Positive Data, Clementia's Palovarotene, Insmed's ALIS

2018-05-23T08:20:33-04:00
Esperion Therapeutics halted pending news

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

26.79

Shares Float (M)

26.04

% Held by Insiders

2.80

% Held by Institutions

Shares Short (K)

3944

Shares Short Prior Month (K)

4110

Stock Financials

EPS

-6.950

EPS Est. Current Year

-7.290

EPS Est. Next Year

-5.590

EPS Est. Next Quarter

-1.790

Forward EPS

-5.180

Book Value (p.s.)

5.280

PEG Ratio

-0.33

Profit Margin

Operating Margin

Return on Assets (ttm)

-75.2

Return on Equity (ttm)

-84.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-4.709

Qtrly Earnings Growth

Operating Cash Flow (M)

-140.21

Levered Free Cash Flow (M)

-77.33

atoplab.com

Valuation

P/E

-5.40

P/E Growth Ratio

P/BV

7.11

P/S

P/CF

-7.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.